Zydus Lifesciences Limited (including its subsidiaries/affiliates hereafter referred to as “Zydus”) an innovation-led global lifesciences company, announced its focus on the development of a combination vaccine against shigellosis and typhoid. This combination vaccine, being developed for the first time in the world, underscores India’s innovation capabilities with the potential to provide protection against deadly enteric […]
The post Zydus Secures Gates Foundation Support to Develop First Shigellosis-Typhoid Combo Vaccine first appeared on Business News Week.
Comments are closed